Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,570 Prostate Cancer
clinical trials

Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Stanford Cancer Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Feather River Cancer Center
mi
from
Paradise, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Singing River Hospital
mi
from
Pascagoula, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Arizona Oncology - Deer Valley Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Beth Israel Deaconess Hospital-Plymouth
mi
from
Plymouth, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Kootenai Cancer Center
mi
from
Post Falls, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Barnes-Jewish West County Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Cancer Care Center, Incorporated
mi
from
Salem, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Arizona Oncology Services Foundation
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Spartanburg Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Arizona Oncology Associates-West Orange Grove
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/29/2016
Sentara Virginia Beach General Hospital
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Urology of Indiana
mi
from
Greenwood, IN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai Comprehensive Cancer Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Springfield Clinic, LLP
mi
from
Springfield, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Urology Institute
mi
from
Springfield, OR
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Skyline Urology
mi
from
Torrance, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Institute of Urology, P.C.
mi
from
Troy, MI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Urologic Surgeons of Washington
mi
from
Washington DC,
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
The Cxbladder Monitoring Study
Status: Enrolling
Updated: 3/4/2016
Urology Centers of Alabama
mi
from
Homewood, AL
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
The Cxbladder Monitoring Study
Status: Enrolling
Updated: 3/4/2016
Premier Medical Group of the Hudson Valley
mi
from
New York, NY
Click here to add this to my saved trials
Neoplasms of the Prostate Clinical Trial
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Status: Enrolling, Phase I, II
Updated: 12/31/1969
John Theurer Cancer Center At Hackensack UMC
mi
from
Hackensack, NJ
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
Arizona Oncology Associates-Wilmot
mi
from
Tucson, AZ
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling, Phase II
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hartford Healthcare Cancer Institute @ Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
Status: Enrolling, Phase II
Updated: 12/31/1969
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Site US10002
mi
from
Dallas, TX
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Site US00122
mi
from
Greensboro, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Site US10023
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Site US00046
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Site US10030
mi
from
Omaha, NE
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Site US10010
mi
from
Washington DC,
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling, Phase II
Updated: 12/31/1969
RUSH University Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Uc Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois Cancer Care
mi
from
Peoria, IL
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Cancer of Prostate Clinical Trial
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Status: Enrolling, Phase
Updated: 12/31/1969
Premier Urology Group
mi
from
Edison, NJ
Click here to add this to my saved trials
Cancer of Prostate Clinical Trial
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Status: Enrolling, Phase
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University Cancer and Blood Center LLC
mi
from
Athens, GA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PSMA PET Imaging of Recurrent Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore Medical Center-Weiler Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Easley
mi
from
Easley, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Butternut
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Genetic Evaluation of Men (GEM)
Status: Enrolling, Phase
Updated: 12/31/1969
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Piedmont Cancer Institute, P.C.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Levine Cancer Institute - Pineville
mi
from
Charlotte, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Levine Cancer Institute - University
mi
from
Charlotte, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
South County Hematology/Oncology
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolinas HealthCare System NorthEast
mi
from
Concord, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Antelope Valley
mi
from
Lancaster, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Levine Cancer Institute-Monroe
mi
from
Monroe, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology Associates - SD
mi
from
San Diego, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 4/26/2018
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ocala Oncology Center
mi
from
Ocala, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic, The
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Keck Medical Center of University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Roseville
mi
from
Roseville, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Yale University School of Medicine/Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
1 … 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 … 66